Fjarde AP Fonden Fourth Swedish National Pension Fund Sells 9,800 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Fjarde AP Fonden Fourth Swedish National Pension Fund reduced its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 12.0% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 72,155 shares of the company’s stock after selling 9,800 shares during the quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in GE HealthCare Technologies were worth $5,641,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. MONECO Advisors LLC acquired a new position in GE HealthCare Technologies during the fourth quarter worth $245,000. Howard Capital Management Inc. lifted its position in GE HealthCare Technologies by 3.0% during the 4th quarter. Howard Capital Management Inc. now owns 10,681 shares of the company’s stock worth $835,000 after buying an additional 313 shares in the last quarter. Wealthspire Advisors LLC boosted its stake in shares of GE HealthCare Technologies by 13.8% during the 4th quarter. Wealthspire Advisors LLC now owns 5,912 shares of the company’s stock worth $462,000 after buying an additional 715 shares during the last quarter. TCW Group Inc. grew its holdings in shares of GE HealthCare Technologies by 10.5% in the 4th quarter. TCW Group Inc. now owns 589,120 shares of the company’s stock valued at $46,057,000 after acquiring an additional 55,768 shares in the last quarter. Finally, Denver PWM LLC increased its position in shares of GE HealthCare Technologies by 26.7% in the fourth quarter. Denver PWM LLC now owns 1,036 shares of the company’s stock valued at $81,000 after acquiring an additional 218 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several brokerages recently commented on GEHC. Citigroup increased their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research report on Thursday, February 13th. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and increased their price objective for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. Finally, Wells Fargo & Company raised their target price on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a research note on Friday, February 14th. One research analyst has rated the stock with a sell rating, three have given a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $97.67.

GE HealthCare Technologies Trading Down 0.6 %

Shares of GE HealthCare Technologies stock opened at $90.57 on Tuesday. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. The business has a fifty day simple moving average of $85.26 and a two-hundred day simple moving average of $85.96. GE HealthCare Technologies Inc. has a 1 year low of $74.51 and a 1 year high of $94.80. The company has a market capitalization of $41.42 billion, a price-to-earnings ratio of 20.92, a P/E/G ratio of 3.19 and a beta of 1.15.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The company had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.33 billion. Research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.